Convatec (LSE:CTEC)
ConvaTec is a global medical products and technologies company, specialising in ostomy care, wound therapeutics, continence and critical care, and infusion devices.
About
Last updated 19-07-2019, 04:30:00pm BSTRelated Articles
-
3 top FTSE 250 value stocks I’d buy today
These unloved FTSE 250 (INDEXFTSE: MCX) dividend stocks look too cheap to Roland Head. Read More »
-
I got this FTSE 250 stock badly wrong. But could the time to buy now be right?
G A Chester revisits a disastrous FTSE 250 (INDEXFTSE:MCX) stock tip, and considers its current valuation and prospects. Read More »
-
Is this dividend-paying mid-cap a steal, down 20% today?
Why I think the market reaction to this quality firm’s update looks fair, but the share now has decent recovery potential. Read More »
-
Top shares for February
We asked our writers to share their top stock picks for the month. Read More »
-
3 stocks trading at 52-week lows I’d buy today
Rupert Hargreaves looks at three companies he believes have been wrongly oversold by investors. Read More »
-
Why I think this stock’s price is looking so unhealthy
Investors should avoid this former high-flying healthcare stock which is now in freefall, says Andrew Ross. Read More »
-
Centrica and Convatec share prices slump 25%+, but could they offer recovery potential?
Do shares in Centrica plc (LON: CNA) and Convatec Group plc (LON: CTEC) offer wide margins of safety? Read More »
-
Two small-caps with millionaire-making potential
These small-cap shares have more than tripled in value over the past five years and may have more in the tank. Read More »
-
Could this fallen FTSE 100 star be the turnaround buy of the decade?
G A Chester discusses the turnaround potential of a fallen FTSE 100 (INDEXFTSE:UKX) hero and another out-of-favour former blue-chip. Read More »
-
Warning: these FTSE 250 investments remain a threat to your wealth
These two FTSE 250 (INDEXFTSE: MCX) investments appear to be overvalued given their growth prospects. Read More »
